By Carolin Arndt Foppa Led by Sven Panke’s Bioprocess Lab at ETH Zurich, a consortium of partners from industry and academia from across Europe recently […]
Read moreAuthor: manager
University Hospital of Zürich
Principle Investigator: PD Dr. Steve Pascolo Expertise: RNA-based therapeutics Steve Pascolo is a co-founder of the mRNA vaccine compant, Curevac. The Pascolo lab utilizes mouse […]
Read more
University of Konstanz – Dept. of Chemistry
Principle Investigator: Prof. Andreas Marx Team members: Svenja Hehn, Julia Gutbrot Expertise: Targeted synthesis and generation of functional molecules and their applications. NEWmRNA revolves, in […]
Read more
KU Leuven – Rega Institute
Principle Investigators: Prof. Piet Herdewijn, Dr. Elisabetta Groaz The KU Leuven team is responsible for designing the challenging novel chemical strategies that need to be […]
Read more
Theraxen SA
Principle investigator: Dr. Philippe Marlière Domain of expertise: Synthetic Biology approaches for drug development The metabolic engineering expertise required for redesigning RNA synthesis will be […]
Read more
CEA – Francois Jacob Institute of Biology
Principle investigators: Dr. Valérie Pezo, Dr. Véronique de Berardinis Expertise: Adaptation of E. coli for xenobiotic metabolism. The metabolic engineering expertise required for redesigning RNA […]
Read more
ETH Zurich – Dept. Biosystems Science and Engineering
Principle investigator & project coordinator: Prof. Sven Panke Team members: Dr. Tania Roberts, Aurellia Galliot Expertise: Bioproduction, xenobiotics and enzyme evolution in E. coli. Prof. […]
Read more